Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

Jung Eun Lee; Tomohito Gohda; William H. Walker; Jan Skupien; Adam M. Smiles; Rita R. Holak; Jackson Jeong; Kevin P. McDonnell; Andrzej S. Krolewski; Monika A. Niewczas

doi:10.1371/journal.pone.0058007

Loading metrics

Open Access

Peer-reviewed

Research Article

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

Jung Eun Lee,

Affiliations Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America, Division of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Tomohito Gohda,

Affiliations Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan
⨯
William H. Walker,

Affiliation Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America
⨯
Jan Skupien,

Affiliations Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland
⨯
Adam M. Smiles,

Affiliation Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America
⨯
Rita R. Holak,

Affiliation Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America
⨯
Jackson Jeong,

Affiliation Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America
⨯
Kevin P. McDonnell,

Affiliation Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America
⨯
Andrzej S. Krolewski,

Affiliations Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Monika A. Niewczas

* E-mail: Monika.Niewczas@joslin.harvard.edu

Affiliations Research Division, Joslin Diabetes Center, Boston, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

Jung Eun Lee,
Tomohito Gohda,
William H. Walker,
Jan Skupien,
Adam M. Smiles,
Rita R. Holak,
Jackson Jeong,
Kevin P. McDonnell,
Andrzej S. Krolewski,
Monika A. Niewczas

Published: March 20, 2013
https://doi.org/10.1371/journal.pone.0058007

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Chronic kidney disease
Is the Subject Area "Chronic kidney disease" applicable to this article?

Thanks for your feedback.
Fibroblast growth factor
Is the Subject Area "Fibroblast growth factor" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.